IRCT2017042323235N9
Completed
Phase 3
Evaluation of clinical and immunological efficacy of sub lingual immunotherapy in patients with allergic rhinitis sensitive to mite
Vice chancellor for research, Mashhad University of Medical Sciences0 sites40 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Perennial allergic rhinitis.
- Sponsor
- Vice chancellor for research, Mashhad University of Medical Sciences
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •approved clinical perennial allergic rhinitis and laboratory diagnosis;the desire of patients to drug treatment and participation in the project
- •Exclusion criteria: Suffering from seasonal allergic rhinitis, a history of autoimmune disease, Consumption of corticosteroids or immunosuppressive drugs, pregnancy, allergic asthma, malnutrition
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Evaluation of therapeutic effects of Crocina in knee osteoarthritisosteoarthritis.Primary osteoarthritis of other jointsM19.0IRCT20190419043318N1Bojnourd University of Medical Sciences60
Active, not recruiting
Phase 1
Clinical efficacy, immunogenicity, clinical tolerability and assessment of safety of gpASIT+TM administered orally, according to two administration schedules, for the prophylaxis of seasonal grass pollen rhinoconjunctivitis - Not availableTreatment of seasonal grass pollen rhinoconjunctivitisMedDRA version: 12.1Level: LLTClassification code 10019170Term: Hay feverEUCTR2010-023176-12-BEBiotech Tools sa414
Completed
Phase 2
Analysis of efficacy and immunomodulatory activity of lenalidomide alone in relapse and refractory multiple myelomaplasma cell myelomaJPRN-UMIN000009927Hematology, Respiratory Medicine and Oncology,Faculty of Medicine, Saga University33
Recruiting
Phase 2
Efficacy stem cells in improving the symptoms of patients with lupusIRCT20130812014333N182Kermanshah University of Medical Sciences20
Active, not recruiting
Phase 1
A study to investigate the clinical and immunological effects on field cancerization in patients treated with PD-1 inhibition for advanced or metastatic cutaneous squamous cell carcinomaadvanced or metastatic cutaneous squamous cell carcinomaMedDRA version: 24.1Level: LLTClassification code 10085908Term: Cutaneous squamous cell carcinomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2021-006372-17-DEMuehlenkreiskliniken AoeR20